Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors
Mihalak, K., Carroll, F., & Luetje, C. (2006). Varenicline is a partial agonist at a4ß2 and a full agonist at a7 neuronal nicotinic receptors. Molecular Pharmacology, 70(3), 801 - 805.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray
A decentralized approach to model national and global food and land use systems